Stable isotopes in the diagnosis and treatment of inherited hyperammonemia

Journal of Pediatric Biochemistry

Volumn 4, Issue 1, 2014, Pages 57-63

  Mew, Nicholas Ah ^a   Yudkoff, Marc ^b   Tuchman, Mendel ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

mass spectrometry; Stable isotopes; urea cycle disorders; ureagenesis

Indexed keywords

EID: 84893646307     PISSN: 18795390     EISSN: 18795404     Source Type: Journal    
DOI: 10.3233/JPB-140106     Document Type: Review

References (44)

1. Urey HC, Huffman JR, Thode HG, Fox M. Concentration of N-15 by chemical methods. J Chem Phys 1937; 5(11): 856-72.
2. Krebs HA, Henseleit K. Untersuchungen ber die Harn- stoffbildung im Tierkrper. Z Physiol Chem 1932; 210: 33-46.
3. San Pietro A, Rittenberg D. A study of the rate of protein synthesis in humans. I. Measurement of the urea pool and urea space. J Biol Chem 1953; 201(1): 445-55.
4. San Pietro A, Rittenberg D. A study of the rate of protein synthesis in humans. II. Measurement of the metabolic pool and the rate of protein synthesis. J Biol Chem 1953; 201(1): 457-73.
5. Schoenheimer R, Rittenberg D. The Application of Isotopes to the Study of Intermediary Metabolism. Science 1938; 87(2254): 221-6.
6. Schoenheimer R, Rittenberg D, Foster GL, Keston AS, Ratner S. The Application of the Nitrogen Isotope N15 for the Study of Protein Metabolism. Science 1938; 88(2295): 599-600.
7. Schoenheimer R, Clarke HT. The dynamic state of body constituents. Cambridge, Mass., Harvard university press; 1942. 3 p., l., -78 p., 2 l. p.
8. Summar M, Tuchman M. Proceedings of a consensus con- ference for the management of patients with urea cycle dis- orders. J Pediatr 2001; 138(1 Suppl): S6-10.
9. Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK et al. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med 1982; 306(23): 1387-92.
10. Batshaw ML, Brusilow SW. Treatment of hyperammonemic coma caused by inborn errors of urea synthesis. J Pediatr 1980; 97(6): 893-900. Epub 1980/12/01.
11. Brusilow SW, Maestri NE. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 1996; 43: 127-70.
12. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 1984; 310(23): 1500-5.
13. Duggleby SL, Waterlow JC. The end-product method of measuring whole-body protein turnover: a review of pub- lished results and a comparison with those obtained by leu- cine infusion. Br J Nutr 2005; 94(2): 141-53.
14. Koletzko B, Demmelmair H, Hartl W, Kindermann A, Koletzko S, Sauerwald T et al. The use of stable isotope techniques for nutritional and metabolic research in paediat- rics. Early Hum Dev 1998; 53 Suppl: S77-97.
15. Wolfe RR, Goodenough RD, Burke JF, Wolfe MH. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg 1983; 197(2): 163-71.
16. Wolfe RR, Chinkes DL. Isotope tracers in metabolic re- search: principles and practice of kinetic analysis. 2nd ed. Hoboken, New Jersey: Wiley-Liss; 2005. vii, pp 474.
17. Preston T, Slater C. Mass spectrometric analysis of stable- isotope-labelled amino acid tracers. Proc Nutr Soc 1994; 53(2): 363-72.
18. Meier-Augenstein W. Use of gas chromatography-combus- tion-isotope ratio mass spectrometry in nutrition and meta- bolic research. Curr Opin Clin Nutr Metab Care 1999; 2(6): 465-70.
19. Meier-Augenstein W. Applied gas chromatography coupled to isotope ratio mass spectrometry. J Chromatogr A 1999; 842(1-2): 351-71.
20. Yudkoff M, Daikhin Y, Nissim I, Jawad A, Wilson J, Bat- shaw M. In vivo nitrogen metabolism in ornithine transcar- bamylase deficiency. The Journal of Clinical Investigation 1996; 98(9): 2167-73.
21. McCullough BA, Yudkoff M, Batshaw ML, Wilson JM, Raper SE, Tuchman M. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. Am J Med Genet 2000; 93(4): 313-9.
22. Lee B, Yu H, Jahoor F, O'Brien W, Beaudet AL, Reeds P. In vivo urea cycle flux distinguishes and correlates with phe- notypic severity in disorders of the urea cycle. Proc Natl Acad Sci USA 2000; 97(14): 8021-6.
23. Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat 2006; 27(7): 626-32.
24. Hberle J, Shchelochkov OA, Wang J, Katsonis P, Hall L, Reiss S et al. Molecular defects in human carbamoy phos- phate synthetase I: mutational spectrum, diagnostic and pro- tein structure considerations. Hum Mutat 2011; 32(6): 579-89.
25. Tuchman M, Lee B, Lichter-Konecki U, Summar ML, Yudkoff M, Cederbaum SD et al. Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab 2008; 94(4): 397-402.
26. Scaglia F, Zheng Q, O'Brien WE, Henry J, Rosenberger J, Reeds P et al. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamyl- ase deficiency. Pediatrics 2002; 109(1): 150-2.
27. Gyato K, Wray J, Huang ZJ, Yudkoff M, Batshaw ML. Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann Neurol 2004; 55(1): 80-6.
28. Tuchman M, Caldovic L, Daikhin Y, Horyn O, Nissim I, Korson M et al. N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers. Pediatr Res 2008; 64(2): 213-7.
29. Coude FX, Sweetman L, Nyhan WL. Inhibition by propionyl- coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest 1979; 64(6): 1544-51.
30. Dercksen M, Ijlst L, Duran M, Mienie LJ, van Cruchten A, van der Westhuizen FH et al. Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short- chain coenzyme A esters and the production of alternative glutamate esters. Biochim Biophys Acta 2013; May 2: S0925-4439(13)00151-8.
31. Glasgow AM, Chase HP. Effect of propionic acid on fatty acid oxidation and ureagenesis. Pediatr Res 1976; 10(7): 683-6.
32. Stewart PM, Walser M. Failure of the normal ureagenic response to amino acids in organic acid-loaded rats. Proposed mechanism for the hyperammonemia of propionic and methylmalonic acidemia. J Clin Invest 1980; 66(3): 484-92.
33. Filippi L, Gozzini E, Fiorini P, Malvagia S, la Marca G, Donati MA. N-carbamylglutamate in emergency manage- ment of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatology 2010; 97(3): 286-90.
34. Gebhardt B, Dittrich S, Parbel S, Vlaho S, Matsika O, Bohles H. N-carbamylglutamate protects patients with decompen- sated propionic aciduria from hyperammonaemia. J Inherit Metab Dis 2005; 28(2): 241-4.
35. Jones S, Reed CA, Vijay S, Walter JH, Morris AA. N-car- bamylglutamate for neonatal hyperammonaemia in propionic acidaemia. J Inherit Metab Dis 2008; 31 Suppl 2: S219-22.
36. Schwahn BC, Pieterse L, Bisset WM, Galloway PG, Robin- son PH. Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic aci- daemia. Eur J Pediatr 2010; 169(1): 133-4.
37. Levesque S, Lambert M, Karalis A, Melancon S, Russell L, Braverman N. Short-term outcome of propionic aciduria treated at presentation with N-carbamylglutamate: a retro- spective review of four patients. JIMD Rep 2012; 2: 97-102.
38. Heibel SK, Ah Mew N, Caldovic L, Daikhin Y, Yudkoff M, Tuchman M. N-carbamylglutamate enhancement of urea- genesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy. Hum Mutat 2011; 32(10): 1153-60.
39. Caldovic L, Morizono H, Daikhin Y, Nissim I, McCarter RJ, Yudkoff M et al. Restoration of ureagenesis in N-acetylglu- tamate synthase deficiency by N-carbamylglutamate. J Pedi- atr 2004; 145(4): 552-4.
40. Moscioni D, Morizono H, McCarter RJ, Stern A, Cabrera- Luque J, Hoang A et al. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcar- bamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors. Mol Ther 2006; 14(1): 25-33.
41. Wang L, Morizono H, Lin J, Bell P, Jones D, McMenamin D et al. Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency re-veals functional enzyme from each persisting vector genome. Mol Genet Metab 2012; 105(2): 203-11.
42. Meyburg J, Hoffmann GF. Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol Genet Metab 2010; 100 Suppl 1: S77-83.
43. Meyburg J, Schmidt J, Hoffmann GF. Liver cell transplanta- tion in children. Clin Transplant 2009; 23 Suppl 21: 75-82.
44. Najimi M, Khuu DN, Lysy PA, Jazouli N, Abarca J, Sem- poux C et al. Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 2007; 16(7): 717-28.